City Pulse Multiplex IPO vs Earum Pharmaceuticals IPO

Comparison between City Pulse Multiplex IPO and Earum Pharmaceuticals IPO.

IPO Details

City Pulse Multiplex IPO is a SME Fixed Price IPO proposed to list at BSE SME while Earum Pharmaceuticals IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of City Pulse Multiplex IPO is up to ₹3.77 Cr whereas the issue size of the Earum Pharmaceuticals IPO is up to ₹6.31 Cr. The final issue price of City Pulse Multiplex IPO is ₹30.00 per share and of Earum Pharmaceuticals IPO is ₹36.00 per share.

 City Pulse Multiplex IPOEarum Pharmaceuticals IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹30.00 per share₹36.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size4000 shares3000 shares
Fresh Issue Size12,56,000 shares17,52,000 shares
Fresh Issue Size (Amount)up to ₹3.77 Crup to ₹6.31 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total12,56,000 shares17,52,000 shares
Issue Size Total (Amount)up to ₹3.77 Crup to ₹6.31 Cr

IPO Timetable

City Pulse Multiplex IPO opens on Jun 27, 2019, while Earum Pharmaceuticals IPO opens on Jun 21, 2019. The closing date of City Pulse Multiplex IPO and Earum Pharmaceuticals IPO is Jul 03, 2019, and Jun 26, 2019, respectively.

 City Pulse Multiplex IPOEarum Pharmaceuticals IPO
Issue OpenJun 27, 2019Jun 21, 2019
Issue CloseJul 03, 2019Jun 26, 2019
Basis Of Allotment (Tentative)Jul 08, 2019Jul 01, 2019
Initiation of Refunds (Tentative)Jul 09, 2019Jul 02, 2019
Credit of Share (Tentative)Jul 09, 2019Jul 03, 2019
Listing date (Tentative)Jul 11, 2019Jul 04, 2019

Financials & KPIs

City Pulse Multiplex IPO P/E ratio is , as compared to Earum Pharmaceuticals IPO P/E ratio of .

 City Pulse Multiplex IPOEarum Pharmaceuticals IPO
Financials

Company Financials (Restated)

Period Ended31 Mar 201931 Mar 201831 Mar 2017
Assets6.163.252.76
Total Income3.090.740.24
Profit After Tax0.590.260.10
EBITDA0.750.280.08
NET Worth2.38-0.54-0.80
Reserves and Surplus1.33-0.79-1.05
Total Borrowing2.623.513.12
Amount in ₹ Crore

Company Financials (Restated)

Period Ended31 Dec 201831 Mar 201831 Mar 201731 Mar 2016
Assets27.4120.5311.088.79
Total Income34.5035.8523.6918.63
Profit After Tax0.870.860.160.10
EBITDA1.931.470.310.47
NET Worth5.084.211.531.37
Reserves and Surplus4.773.901.421.26
Total Borrowing7.897.232.081.90
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)65.73%100%
Promoter Shareholding (Post-Issue)39.43%70.04%
Market Cap₹99.54 Cr.₹22.20 Cr.

Shares Offered

In the City Pulse Multiplex IPO Retail Individual Investors (RII) are offered 6,28,000 shares while in Earum Pharmaceuticals IPO retail investors are offered 6,28,000 shares. Qualified Institutional Buyers (QIB) are offered in City Pulse Multiplex IPO and in Earum Pharmaceuticals IPO.

 City Pulse Multiplex IPOEarum Pharmaceuticals IPO
Market Maker Reservation72,000 shares96,000 shares
NII6,28,000 shares8,76,000 shares
RII6,28,000 shares8,76,000 shares
Total12,56,000 shares17,52,000 shares

Bids Received (Subscription)

City Pulse Multiplex IPO subscribed 3.00x in total, whereas Earum Pharmaceuticals IPO subscribed 1.60x.

Compare with others

Compare:

City Pulse Multiplex IPO Vs Earum Pharmaceuticals IPO